| Literature DB >> 18941117 |
Yan-Fang Fu1, Ting-Ting Du, Mei Dong, Kang-Yong Zhu, Chang-Bin Jing, Yong Zhang, Lei Wang, Hong-Bo Fan, Yi Chen, Yi Jin, Gui-Ping Yue, Sai-Juan Chen, Zhu Chen, Qiu-Hua Huang, Qing Jing, Min Deng, Ting Xi Liu.
Abstract
Precise transcriptional control of developmental stage-specific expression and switching of alpha- and beta-globin genes is significantly important to understand the general principles controlling gene expression and the pathogenesis of thalassemia. Although transcription factors regulating beta-globin genes have been identified, little is known about the microRNAs and trans-acting mechanism controlling alpha-globin genes transcription. Here, we show that an erythroid lineage-specific microRNA gene, miR-144, expressed at specific developmental stages during zebrafish embryogenesis, negatively regulates the embryonic alpha-globin, but not embryonic beta-globin, gene expression, through physiologically targeting klfd, an erythroid-specific Krüppel-like transcription factor. Klfd selectively binds to the CACCC boxes in the promoters of both alpha-globin and miR-144 genes to activate their transcriptions, thus forming a negative feedback circuitry to fine-tune the expression of embryonic alpha-globin gene. The selective effect of the miR-144-Klfd pathway on globin gene regulation may thereby constitute a novel therapeutic target for improving the clinical outcome of patients with thalassemia.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18941117 DOI: 10.1182/blood-2008-08-174854
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113